Skip to content

Chris LaVictoire Mahai, Director at abrdn Healthcare Investors, bought HQH on Jul 16, 2026

Data as of Oct 16

▲ BUY$10.5K501 shares at $20.96Chris LaVictoire Mahai DirectorHQH abrdn Healthcare Investors
Watch HQH
Traded
Jul 16, 2026
Disclosed
Jul 20, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Chris LaVictoire Mahai, Director at abrdn Healthcare Investors, bought HQH on Jul 16, 2026TRADEDDISCLOSED
HQHSimilar stocks (XLF — its sector index fund), rebased to HQH's price on the disclosure day
HQH since disclosure
−9.2%
Similar stocks (XLF) since disclosure
−0.9%
XLF — its sector index fund

Change in closing price from Jul 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on HQH →